Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Progressive BioActives Inc. was a Canadian biotechnology company based in Charlottetown, Prince Edward Island, specializing in the development of natural bioactive ingredients. The company focused on high-value compounds derived from natural sources for applications in animal health, functional foods, and nutraceuticals. Their core expertise involved the formulation and stabilization of carotenoid-based products designed to enhance immune function and overall health. A key area of their research was the development of oxidized beta-carotene as a non-antibiotic alternative for promoting growth and health in livestock. In 2008, the company was acquired by Avivagen Inc. (formerly Chemaphor Inc.), which integrated PBI's technology into its own platform. The acquisition allowed for the further commercialization of the OxC-beta™ technology, which remains a cornerstone of Avivagen's product offerings today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Progressive BioActives.